Cosmetic: Ideas and Innovation
Jabbour, Samer F. M.D.; Awaida, Cyril J. M.D.; ElKhoury, Joseph S. M.D.; Rayess, Youssef A. M.D.; Makhoul, Rani B. M.D.; Kechichian, Elio G. M.D.; Nasr, Marwan W. M.D.
Beirut, Lebanon; and Paris, France
From the Departments of Plastic and Reconstructive Surgery and Dermatology, Faculty of Medicine Saint-Joseph University; and Policlinique Esthétique Marigny Vincennes.
Received for publication October 19, 2017; accepted April 12, 2018.
This trial is registered under the name “Frontalis Botulinum Toxin,” ClinicalTrials.gov identification number NCT03186001 (https://clinicaltrials.gov/ct2/show/NCT03186001?term=botulinum+forehead&cntry1=ME%3ALB&rank=1).
Disclosure:All the authors have no financial information to disclose. No funding was received for the article.
Supplemental digital content is available for this article. Direct URL citations appear in the text; simply type the URL address into any Web browser to access this content. Clickable links to the material are provided in the HTML text of this article on the Journal’s website (www.PRSJournal.com).
Samer F. Jabbour, M.D., Faculty of Medicine, Saint-Joseph University, Damascus Street, BP 17-5208 - Mar Mikhaël, Beirut, Lebanon 1104 2020, [email protected]
doi: 10.1097/PRS.0000000000004836